Rottenstein Law Group Encouraged by Multidistrict Litigation Consolidation of Federal Fosamax Matter

Rottenstein Law Group Encouraged by Multidistrict Litigation Consolidation of Federal Fosamax Matters The Rottenstein Law Group, which represents clients with claims stemming from the severe side effects of the drug Fosamax, is encouraged by the consolidation of federal Fosamax matters for purposes of pretrial procedures. New York, NY (PRWEB) May 30, 2011 By order dated May 23, 2011, the United States Panel on Multidistrict Litigation in case number MDL 2243 (In Re: Fosamax (Alendronate Sodium) Products Liability Litigation (No. II)) ordered that 36 actions against defendant Merck Sharp &
Contributor
About
PRWeb, a leader in online news and press release distribution, has been used by attorneys, law firms and more than 40,000 organizations